-
Signature
-
/s/ Jonathan Golightly, attorney-in-fact
-
Stock symbol
-
RXRX
-
Transactions as of
-
Dec 4, 2024
-
Transactions value $
-
-$285,600
-
Form type
-
4
-
Date filed
-
12/6/2024, 05:46 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
RXRX |
Class A Common Stock |
Conversion of derivative security |
$0 |
+20K |
+2.72% |
$0.00 |
757K |
Dec 4, 2024 |
Direct |
F1, F2 |
transaction |
RXRX |
Class A Common Stock |
Sale |
-$143K |
-20K |
-2.64% |
$7.16 |
737K |
Dec 4, 2024 |
Direct |
F2 |
transaction |
RXRX |
Class A Common Stock |
Conversion of derivative security |
$0 |
+20K |
+2.72% |
$0.00 |
757K |
Dec 5, 2024 |
Direct |
F1, F2 |
transaction |
RXRX |
Class A Common Stock |
Sale |
-$142K |
-20K |
-2.64% |
$7.12 |
737K |
Dec 5, 2024 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
RXRX |
Class B Common Stock |
Conversion of derivative security |
$0 |
-20K |
-0.33% |
$0.00 |
6.04M |
Dec 4, 2024 |
Class A Common Stock |
20K |
$0.00 |
Direct |
F1, F2, F3 |
transaction |
RXRX |
Class B Common Stock |
Conversion of derivative security |
$0 |
-20K |
-0.33% |
$0.00 |
6.02M |
Dec 5, 2024 |
Class A Common Stock |
20K |
$0.00 |
Direct |
F1, F2, F3 |
holding |
RXRX |
Class B Common Stock |
|
|
|
|
|
486K |
Dec 4, 2024 |
Class A Common Stock |
0 |
$0.00 |
by LAHWRAN-3 LLC |
F3, F4 |
holding |
RXRX |
Class B Common Stock |
|
|
|
|
|
388K |
Dec 4, 2024 |
Class A Common Stock |
0 |
$0.00 |
by LAHWRAN-4 LLC |
F3, F5 |
holding |
RXRX |
Class B Common Stock |
|
|
|
|
|
67.9K |
Dec 4, 2024 |
Class A Common Stock |
0 |
$0.00 |
by Gibson Family Trust |
F3, F6 |
holding |
RXRX |
Stock Option (Right to Buy) |
|
|
|
|
|
283K |
Dec 4, 2024 |
Class A Common Stock |
0 |
$2.48 |
Direct |
F7 |
holding |
RXRX |
Stock Option (Right to Buy) |
|
|
|
|
|
814K |
Dec 4, 2024 |
Class A Common Stock |
0 |
$8.55 |
Direct |
F8 |
holding |
RXRX |
Stock Option (Right to Buy) |
|
|
|
|
|
399K |
Dec 4, 2024 |
Class A Common Stock |
0 |
$11.40 |
Direct |
F9 |
holding |
RXRX |
Stock Option (Right to Buy) |
|
|
|
|
|
5.44K |
Dec 4, 2024 |
Class A Common Stock |
0 |
$11.40 |
Direct |
|
holding |
RXRX |
Stock Option (Right to Buy) |
|
|
|
|
|
667K |
Dec 4, 2024 |
Class A Common Stock |
0 |
$10.09 |
Direct |
F10 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: